Levomilnacipran (F2695), a norepinephrine-preferring SNRI: Profile in vitro and in models of depression and anxiety-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Levomilnacipran (F2695), a norepinephrine-preferring SNRI: Profile in vitro and in models of depression and anxiety

Published:2013-07 Issue: Volume:70 Page:338-347
ISSN:0028-3908
Container-title:Neuropharmacology
language:en
Short-container-title:Neuropharmacology

Author:

Auclair A.L.,Martel J.C.,Assié M.B.,Bardin L.,Heusler P.,Cussac D.,Marien M.,Newman-Tancredi A.,O'Connor J.A.,Depoortère R.

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Pharmacology

Reference49 articles.

1. The epidemiology of major depressive episodes: results from the International Consortium of Psychiatric Epidemiology (ICPE) surveys;Andrade;Int. J. Methods Psychiatry Res.,2003

2. Chronic oral nicotine increases brain [3H]epibatidine binding and responsiveness to antidepressant drugs, but not nicotine, in the mouse forced swim test;Andreasen;Psychopharmacology,2009

3. Comparison of milnacipran, duloxetine and pregabalin in the formalin pain test and in a model of stress-induced ultrasonic vocalizations in rats;Bardin;Neurosci. Res.,2010

4. Cooperative opioid and serotonergic mechanisms generate superior antidepressant-like effects in a mice model of depression;Berrocoso;Int. J. Neuropsychopharmacol.,2009

5. Role of serotonin 5-HT1A receptors in the antidepressant-like effect and the antinociceptive effect of venlafaxine in mice;Berrocoso;Int. J. Neuropsychopharmacol.,2009

Cited by 143 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and Efficacy of Levomilnacipran Extended Release in Pediatric Patients Aged 7–17 Years with Major Depressive Disorder: Results of Two Phase 3, Randomized, Double-Blind Studies;Journal of Child and Adolescent Psychopharmacology;2024-06-01

2. LEVOMILNACIPRAN;Prescriber's Guide;2024-04-18

3. Genetically encoded sensors for in vivo detection of neurochemicals relevant to depression;Journal of Neurochemistry;2024-03-11

4. 2-Phenylcyclopropylmethylamine (PCPMA) as a privileged scaffold for central nervous system drug design;Bioorganic & Medicinal Chemistry Letters;2024-03

5. Chirality of New Drug Approvals (2013–2022): Trends and Perspectives;Journal of Medicinal Chemistry;2024-02-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3